| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |